Skip to Main Content

OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings

Conditions

HIV/AIDS | Women's Health

Phase IV

What is the purpose of this trial?

Brief Summary:

To develop and test the effect of a patient-centered HIV prevention decision aid on HIV pre-exposure prophylaxis (PrEP) uptake among women with substance use disorders (SUD) in treatment.

  • Ages
    18 years and older
  • Gender
    Female only
  • Trial with
    Doris Duke Charitable Foundation
  • Start Date
    10/01/2017
  • End Date
    10/30/2020
Trial Image

For more information about this study, contact:

Tequetta Valeriano

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    09/05/2019
  • Study HIC
    #2000021561